{"Ticker": "CTVA", "Company": "Corteva", "Sector": "Materials", "Updated": "2022-01-31", "Rating": [{"Date": "2022-01-31", "Rating": "Upgrade", "Organization": "Redburn", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2021-10-18", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2021-10-13", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$53"}, {"Date": "2021-10-08", "Rating": "Initiated", "Organization": "ROTH Capital", "Rating_Change": "Buy", "Target_Change": "$53"}, {"Date": "2021-09-01", "Rating": "Initiated", "Organization": "Berenberg", "Rating_Change": "Buy", "Target_Change": "$58"}, {"Date": "2021-08-09", "Rating": "Upgrade", "Organization": "Monness Crespi & Hardt", "Rating_Change": "Sell to Neutral", "Target_Change": ""}, {"Date": "2021-05-10", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Underperform", "Target_Change": "$50 to $42"}, {"Date": "2021-04-19", "Rating": "Upgrade", "Organization": "Loop Capital", "Rating_Change": "Hold to Buy", "Target_Change": "$54"}, {"Date": "2021-02-05", "Rating": "Upgrade", "Organization": "JP Morgan", "Rating_Change": "Neutral to Overweight", "Target_Change": "$51"}, {"Date": "2021-02-05", "Rating": "Reiterated", "Organization": "Monness Crespi & Hardt", "Rating_Change": "Sell", "Target_Change": "$24 to $32"}, {"Date": "2020-12-18", "Rating": "Downgrade", "Organization": "Susquehanna", "Rating_Change": "Positive to Neutral", "Target_Change": ""}, {"Date": "2020-12-14", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$46"}, {"Date": "2020-11-10", "Rating": "Upgrade", "Organization": "Argus", "Rating_Change": "Hold to Buy", "Target_Change": "$42"}, {"Date": "2020-10-19", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$40"}, {"Date": "2020-10-19", "Rating": "Downgrade", "Organization": "Exane BNP Paribas", "Rating_Change": "Outperform to Underperform", "Target_Change": ""}, {"Date": "2020-08-11", "Rating": "Upgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Overweight", "Target_Change": "$31"}, {"Date": "2020-08-10", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$28"}, {"Date": "2020-07-13", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Underperform to Buy", "Target_Change": ""}, {"Date": "2020-06-26", "Rating": "Initiated", "Organization": "Cleveland Research", "Rating_Change": "Neutral", "Target_Change": ""}, {"Date": "2020-06-16", "Rating": "Upgrade", "Organization": "Vertical Research", "Rating_Change": "Hold to Buy", "Target_Change": ""}, {"Date": "2020-06-08", "Rating": "Downgrade", "Organization": "Monness Crespi & Hardt", "Rating_Change": "Neutral to Sell", "Target_Change": "$24"}]}